Ketamine Therapy Explained: What It Is, How It Works and Possible Side Effects

Ketamine Therapy: How It Works, Benefits and Side Effects

Ketamine therapy has emerged as one of the most discussed developments in modern mental healthcare. Although ketamine has been used as an anesthetic for decades, researchers and clinicians are now studying and administering lower doses for treatment-resistant depression, certain chronic pain conditions and other difficult-to-treat health concerns.

For some patients, ketamine may begin relieving depressive symptoms much faster than conventional antidepressants. That possibility has created genuine excitement—but “promising” does not mean risk-free, universally effective or appropriate for unsupervised use.

Here is what patients and families should know about ketamine therapy, how it may work and the potential side effects involved.

What Is Ketamine Therapy?

Ketamine therapy is the medically supervised administration of ketamine or a closely related medication for a specific therapeutic purpose.

Ketamine hydrochloride is a dissociative anesthetic. At anesthetic doses, it can produce unconsciousness and pain relief. At lower doses, it may temporarily affect mood, perception and a person’s sense of connection to their body or surroundings.

According to the Cleveland Clinic’s overview of ketamine therapy, healthcare providers may consider the treatment when more conventional options have not worked. Depending on the condition and clinical setting, ketamine may be administered through an intravenous infusion. Some providers also prescribe other formulations off-label.

It is important to distinguish ketamine from esketamine.

Esketamine, sold under the brand name Spravato, is a nasal spray containing one molecular form of ketamine. The U.S. Food and Drug Administration has approved it for specific depressive disorders under controlled conditions. It must be administered in a certified healthcare setting, where the patient is monitored afterward.

Ketamine itself is FDA-approved as an anesthetic, but it is not FDA-approved to treat depression or other psychiatric disorders. When a clinician prescribes ketamine for a psychiatric condition, it is considered an off-label use.

Off-label prescribing is legal and common throughout medicine, but patients should understand the limits of the evidence and the differences between ketamine products and treatment protocols.

What Is Ketamine Therapy Used For?

Interest in ketamine therapy has largely focused on treatment-resistant depression. This generally describes depression that has not improved adequately after a patient has tried other appropriate treatments.

Healthcare professionals may also consider ketamine in certain circumstances involving:

  • Major depressive disorder
  • Depressive symptoms accompanied by acute suicidal thoughts
  • Certain chronic or severe pain conditions
  • Post-traumatic stress disorder
  • Anxiety disorders
  • Status epilepticus in hospital settings

The quality of the evidence is not identical for every condition on this list. Some uses remain experimental or off-label, and encouraging early findings should not be mistaken for an established FDA approval.

Ketamine is also not typically the first treatment a patient receives. A responsible provider should review previous treatments, current medications, physical health, psychiatric history and substance-use risk before recommending it.

How Does Ketamine Therapy Work?

Ketamine acts differently from most conventional antidepressants.

Many commonly prescribed antidepressants primarily influence serotonin, norepinephrine or dopamine. Ketamine’s best-understood action involves glutamate, the brain’s most abundant excitatory neurotransmitter.

Ketamine blocks a type of glutamate receptor called the N-methyl-D-aspartate receptor, or NMDA receptor. This appears to influence other signaling pathways, including activity involving AMPA receptors.

Researchers believe these changes may promote synaptic plasticity—the brain’s ability to strengthen, reorganize and form neural connections.

One way to think about neuroplasticity is as the brain’s capacity to revise old patterns. Depression can become associated with rigid cycles of thought, emotion and behavior. Ketamine may temporarily create conditions in which healthier signaling and new connections become more possible.

That does not mean ketamine simply “rewires the brain” during one appointment. Its precise antidepressant mechanisms remain under investigation, and medication is only one possible part of a patient’s broader care.

Why Can Ketamine Work Faster Than Traditional Antidepressants?

Traditional antidepressants often require several weeks of regular use before a patient knows whether they are helping. Ketamine’s effects can appear much more quickly in some people—sometimes within hours or days.

That speed is one of ketamine therapy’s most important potential advantages, particularly for patients experiencing severe symptoms after other treatments have failed.

Fast action, however, does not necessarily mean permanent relief.

The benefits may diminish over time, and some patients undergo an initial series of treatments followed by maintenance appointments. Others experience little or no meaningful improvement.

The goal should be an individualized and medically responsible treatment plan—not the promise of an instant cure.

What Happens During a Ketamine Therapy Session?

The experience depends on the medication, route of administration, clinic and condition being treated.

Before recommending treatment, a responsible clinic will generally review:

  • The patient’s physical and psychiatric history
  • Current prescriptions, supplements and substance use
  • Blood pressure and cardiovascular health
  • Previous reactions to anesthesia
  • Any history of psychosis, mania or substance-use disorder
  • Pregnancy or breastfeeding status when relevant
  • Transportation and post-treatment recovery plans

During an intravenous ketamine infusion, the medication is administered gradually while clinical staff monitor the patient. Providers may track blood pressure, heart rate, oxygen levels and psychological responses.

A patient might feel relaxed, dreamlike, unusually introspective or temporarily detached from their body and surroundings. Time and space may feel different. Some people find the experience calming, while others may feel confused or anxious.

A dramatic subjective experience does not necessarily mean that the treatment is working.

Esketamine nasal spray is administered under supervision at a certified healthcare facility. Patients must remain under observation afterward because sedation, dissociation and changes in blood pressure may occur.

Patients should not drive themselves home following treatment and should carefully follow the clinic’s instructions regarding medications, food, beverages and activities.

What Are the Most Common Ketamine Side Effects?

Ketamine may produce temporary physical and psychological effects even when it is administered correctly.

Common ketamine side effects include:

  • Dissociation or feeling detached
  • Dizziness
  • Drowsiness or sedation
  • Nausea and vomiting
  • Increased blood pressure
  • Increased heart rate
  • Blurred or altered vision
  • Headache
  • Confusion or disorientation
  • Anxiety, agitation or fear
  • Changes in sensory perception

These effects frequently lessen as the medication wears off, but each person responds differently. Proper clinical monitoring allows providers to identify complications, reassure the patient and intervene when necessary.

What Are the More Serious Risks of Ketamine?

Ketamine can be used safely in appropriate medical environments, but it remains a powerful prescription medication and federally controlled substance.

Cardiovascular effects

Ketamine can temporarily increase blood pressure and heart rate. People with uncontrolled hypertension, certain aneurysms, serious cardiovascular disease or related medical conditions may face greater risk.

Excessive sedation or breathing problems

Sedation can impair awareness, coordination and judgment. The risks may increase when ketamine is combined with alcohol, opioids, benzodiazepines or other central nervous system depressants.

Patients must tell their providers about every medication and substance they use.

Distressing psychological reactions

Dissociation may feel calming or insightful to one person and frightening to another. Ketamine can also produce confusion, panic, perceptual disturbances or worsening psychiatric symptoms.

Patients with a history of psychosis or certain other psychiatric conditions require particularly careful evaluation.

Misuse, tolerance and dependence

Ketamine has abuse potential. Repeated nonmedical use can result in tolerance, dependence and serious physical or psychological harm.

A responsible treatment program should assess substance-use risk, track outcomes and avoid automatically increasing the amount or frequency of treatment without reevaluation.

Urinary and bladder problems

Frequent or heavy ketamine exposure has been associated with urinary symptoms and potentially severe bladder damage. Although these problems are most strongly associated with repeated misuse, patients receiving ongoing treatment should report urinary changes promptly.

Liver and cognitive concerns

Repeated exposure may affect liver function or cognition in some circumstances. The long-term safety of every psychiatric dosing schedule and formulation has not yet been fully established.

The FDA has warned about potential risks associated with compounded ketamine products, particularly when patients use them at home without onsite medical monitoring.

Compounded medications do not undergo the same FDA review for safety, effectiveness and manufacturing quality as approved drug products.

Who May Not Be a Good Candidate for Ketamine Therapy?

Ketamine treatment is not appropriate for everyone.

A healthcare provider may recommend another approach for someone with:

  • Uncontrolled high blood pressure
  • A recent heart attack or serious cardiovascular condition
  • An aneurysm or aortic dissection
  • A history of psychosis
  • Certain cases of bipolar disorder or a high risk of mania
  • A ketamine allergy or previous serious reaction
  • A significant history or elevated risk of substance misuse
  • Certain liver, urinary or neurological conditions
  • Pregnancy or breastfeeding, depending on the circumstances

This is not a complete screening list. Eligibility should be determined through an individualized medical and psychiatric assessment—not merely an online questionnaire.

Ketamine Versus Esketamine: What Is the Difference?

Although the terms are sometimes used interchangeably, ketamine and esketamine are not the same treatment.

Feature Ketamine Esketamine
Medication Contains two mirror-image molecular forms Contains one specific form of the ketamine molecule
Common psychiatric route Usually IV, although other off-label formulations exist Nasal spray
FDA status Not FDA-approved for psychiatric disorders FDA-approved for specific depressive indications
Treatment environment Practices vary, but supervised treatment provides important monitoring Must be administered under supervision in a certified healthcare setting
Insurance coverage Often limited because psychiatric use is off-label May be covered when eligibility requirements are met

Patients should ask exactly which medication, formulation and treatment protocol a clinic provides. “Ketamine therapy” is not one universally standardized procedure.

Does Ketamine Therapy Include Psychotherapy?

Sometimes—but not always.

A clinic may provide ketamine primarily as a biological treatment, accompanied by symptom monitoring and medication management.

Ketamine-assisted psychotherapy, sometimes called KAP, intentionally combines the medication with preparation, therapeutic support and integration sessions.

Supporters believe psychotherapy may help patients constructively use the increased psychological flexibility or altered perspective that can accompany ketamine treatment. However, the ideal therapy method, timing and number of sessions remain active areas of research.

Patients should ask whether psychotherapy is included, who provides it, what credentials that person possesses and whether the quoted price includes preparation and integration appointments.

How to Evaluate a Ketamine Clinic

A polished website and an attractive treatment room do not necessarily guarantee responsible care.

Before selecting a provider, consider asking:

  • Who conducts the medical and psychiatric screening?
  • Which licensed clinician prescribes and administers the medication?
  • Which formulation and route of administration are used?
  • Is the proposed use FDA-approved or off-label?
  • How are blood pressure, oxygen levels and psychological symptoms monitored?
  • What emergency equipment and procedures are available?
  • How does the provider determine whether treatment is working?
  • What happens if the patient’s symptoms worsen?
  • How are misuse risk and long-term side effects assessed?
  • Is psychotherapy included or offered separately?
  • What is the total cost, including possible maintenance treatments?
  • Will the clinic coordinate with the patient’s existing physician or therapist?

Be cautious of clinics promising guaranteed results, describing ketamine as a universal cure or providing large quantities for unsupervised use without meaningful medical oversight.

Frequently Asked Questions About Ketamine Therapy

Is ketamine a psychedelic?

Ketamine is generally classified as a dissociative anesthetic rather than a classic psychedelic. It works differently from substances such as psilocybin or LSD.

However, its ability to produce altered states and its potential therapeutic applications have placed it within the broader public conversation surrounding psychedelic medicine.

Is ketamine therapy legal?

Yes. Ketamine is a legal prescription medication and a Schedule III controlled substance in the United States.

Its use as an anesthetic is FDA-approved. Licensed clinicians may also prescribe it off-label for psychiatric or pain-related conditions when they consider doing so medically appropriate.

Is ketamine FDA-approved for depression?

Ketamine itself is not FDA-approved to treat depression or another psychiatric disorder.

Esketamine nasal spray is FDA-approved for specific depressive indications and must be used under required clinical supervision.

How quickly can ketamine work for depression?

Some patients experience improvement within hours or days—much faster than the typical onset of conventional antidepressants.

Other patients require multiple sessions, experience only temporary benefits or do not respond.

How long do the effects last?

The altered or dissociative effects experienced during a treatment session are temporary.

Therapeutic benefits may persist longer, but their duration varies considerably. Some patients receive maintenance treatment, while others discontinue because of side effects, limited improvement, cost or personal preference.

Can ketamine cure depression?

No responsible healthcare provider should promise that ketamine will cure depression.

Ketamine may reduce symptoms for some patients, particularly those with treatment-resistant depression, but symptoms can return and continuing mental-health care may remain necessary.

Is at-home ketamine therapy safe?

At-home treatment deserves special caution because sedation, dissociation, blood-pressure changes and other complications can occur without immediate clinical assistance.

The FDA has expressed concerns about compounded ketamine used for psychiatric conditions, including the risks associated with unsupervised administration.

The Bottom Line on Ketamine Therapy

Ketamine therapy represents an important change in how scientists and clinicians think about difficult-to-treat depression and pain. Its rapid action and effects on glutamate signaling may offer hope to certain patients who have not improved with conventional treatment.

But ketamine is not a wellness shortcut, guaranteed cure or medication to approach casually. Benefits vary, major research questions remain and safety depends heavily on patient screening, formulation, dosage, supervision and follow-up care.

The most useful question is not whether ketamine is a miracle or a menace. It is whether a particular form of medically supervised ketamine treatment is appropriate for a particular patient.

At Learn Euphoria, we believe better conversations about emerging therapies begin with honest education: what the evidence supports, what remains uncertain and what questions people should ask before making a healthcare decision.

This article is for educational purposes only and does not constitute medical advice. Do not begin, discontinue or alter a treatment without consulting a qualified healthcare professional. If you or someone you know is experiencing a mental-health crisis in the United States, call or text 988. Call 911 in an immediate emergency.

Related Articles

Ketamine Therapy Arrives in South Florida: What Patients Should Know

Ketamine therapy is gaining ground in South Florida as patients and mental-health professionals search for new options beyond conventional antidepressants. NBC 6 South Florida recently…

Trump Reaffirms Push for Psychedelic Therapy Research for Veterans

President Donald Trump has reaffirmed his administration’s commitment to accelerating research into psychedelic-assisted therapies for veterans living with post-traumatic stress disorder, treatment-resistant depression, traumatic brain…

Ketamine Therapy Expands in South Florida as Mental Health Treatment Evolves

South Florida’s mental health treatment landscape is changing as medically supervised ketamine therapy becomes more widely available to people who have struggled to find relief…

USF Health Launches Psychedelic Clinical Trials for Depression, Anxiety and PTSD

USF Health Is Studying Psychedelic Treatments for Depression, Anxiety and PTSD Psychedelic medicine research is no longer happening only in California laboratories, underground therapy circles…

VA and Compass Pathways Launch Psilocybin Study for Veterans With Treatment-Resistant Depression

The U.S. Department of Veterans Affairs is moving psychedelic research deeper into mainstream medicine. On August 6, 2026, Compass Pathways announced that it is working…